Safety of NNC 0172-0000-2021 in Healthy Male Subjects and Subjects With Haemophilia A or B

NCT01228669 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

52

Enrollment

INDUSTRY

Sponsor class

Conditions

Congenital Bleeding Disorder
Haemophilia A
Haemophilia B
Healthy

Interventions

DRUG: NNC 0172-0000-2021
DRUG: NNC 0172-0000-2021
DRUG: placebo

Sponsor

Novo Nordisk A/S